These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 24724750)
1. Determinants of adherence in a cohort of Belgian HIV patients: a pilot study. Degroote S; Vogelaers D; Vermeir P; Mariman A; De Rick A; Van Der Gucht B; Pelgrom J; Van Wanzeele F; Verhofstede C; Vancauwenberghe J; Vandijck D Acta Clin Belg; 2014 Apr; 69(2):111-5. PubMed ID: 24724750 [TBL] [Abstract][Full Text] [Related]
2. Socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study. Degroote S; Vogelaers DP; Vermeir P; Mariman A; De Rick A; Van Der Gucht B; Pelgrom J; Van Wanzeele F; Verhofstede C; Vandijck DM J Int AIDS Soc; 2013 Dec; 16(1):18643. PubMed ID: 24331754 [TBL] [Abstract][Full Text] [Related]
3. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups. Dworkin MS; Douglas GW; Sabitha Rani GP; Chakraborty A Int J STD AIDS; 2016 Mar; 27(3):186-95. PubMed ID: 25801316 [TBL] [Abstract][Full Text] [Related]
4. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain. Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167 [TBL] [Abstract][Full Text] [Related]
5. Non-adherence to antiretroviral therapy in Yaounde: prevalence, determinants and the concordance of two screening criteria. Pefura-Yone EW; Soh E; Kengne AP; Balkissou AD; Kuaban C J Infect Public Health; 2013 Aug; 6(4):307-15. PubMed ID: 23806707 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia. Azmeraw D; Wasie B Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria. Alakija Kazeem Salami ; Fadeyi A; Ogunmodede JA; Desalu O J Int Assoc Physicians AIDS Care (Chic); 2010; 9(3):191-5. PubMed ID: 20530474 [TBL] [Abstract][Full Text] [Related]
9. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence. Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395 [TBL] [Abstract][Full Text] [Related]
10. Influence of adding etravirine on complexity index and patients' perceived complexity. Calvo-Cidoncha E; González-Bueno J; Almeida-González CV; Morillo-Verdugo R J Clin Pharm Ther; 2014 Apr; 39(2):154-7. PubMed ID: 24372048 [TBL] [Abstract][Full Text] [Related]
11. Vets, denialists and rememberers: social typologies of patient adherence and non-adherence to HAART from the perspective of HIV care providers. Orchard T; Salters K; Palmer A; Michelow W; Lepik KJ; Hogg R AIDS Care; 2015; 27(6):758-61. PubMed ID: 25635938 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica. Harvey KM; Carrington D; Duncan J; Figueroa JP; Hirschorn L; Manning D; Jackson S West Indian Med J; 2008 Jun; 57(3):293-7. PubMed ID: 19583131 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP; J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563 [TBL] [Abstract][Full Text] [Related]
14. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. Webb MS; Vanable PA; Carey MP; Blair DC AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957 [TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
16. Adherence to HAART: processes explaining adherence behavior in acceptors and non-acceptors. Vervoort SC; Grypdonck MH; de Grauwe A; Hoepelman AI; Borleffs JC AIDS Care; 2009 Apr; 21(4):431-8. PubMed ID: 19266408 [TBL] [Abstract][Full Text] [Related]
17. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study. Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762 [TBL] [Abstract][Full Text] [Related]
19. Validation of the Special Projects of National Significance adherence tool in HIV/AIDS patients. Julian FS; Martin P; Erickson SR Ann Pharmacother; 2010 Jun; 44(6):1003-9. PubMed ID: 20442352 [TBL] [Abstract][Full Text] [Related]
20. Adherence to antiretroviral therapy in conflict areas: a study among patients receiving treatment from Lacor Hospital, Uganda. Garang PG; Odoi RA; Kalyango JN AIDS Patient Care STDS; 2009 Sep; 23(9):743-7. PubMed ID: 19645621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]